This topic contains a solution. Click here to go to the answer

Author Question: A vector object automatically expands in size to accommodate the items stored in it. (Read 31 times)

kwoodring

  • Hero Member
  • *****
  • Posts: 560
A vector object automatically expands in size to accommodate the items stored in it.
◦ true
◦ false


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by kwoodring on May 22, 2019

Kedrick2014

  • Sr. Member
  • ****
  • Posts: 359
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 25% of students answer this correctly




kwoodring

  • Member
  • Posts: 560
Reply 2 on: May 22, 2019
Excellent


dreamfighter72

  • Member
  • Posts: 355
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library